SCHEMBL503237

SCHEMBL503237

CC(=O)OC(C)(C)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13286223 0.81 GAA (0.40)
SCHEMBL1103927 0.80 GAA (0.48)
SCHEMBL8813127 0.79
SCHEMBL8813132 0.79
SCHEMBL10456471 0.78 GAA (0.50)
SCHEMBL9138775 0.78 GAA (0.56)
SCHEMBL8813842 0.77
SCHEMBL8813849 0.77
SCHEMBL1921788 0.77
SCHEMBL14509463 0.77 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884564-B2 Fluorinated polymers having ester groups and photoresists for microlithography E. I. DU PONT DE NEMOURS AND COMPANY (US) 2005-04-26 US claimed
US-20040180287-A1 Fluorinated polymers having ester groups and photoresists for microlithography E.I. DU PONT DE NEMOURS AND COMPANY 2004-09-16 US claimed
EP-1438635-A1 FLUORINATED POLYMERS HAVING ESTER GROUPS AND PHOTORESISTS FOR MICROLITHOGRAPHY E. I. du Pont de Nemours and Company (US) 2004-07-21 EP claimed
WO-2003040827-A1 FLUORINATED POLYMERS HAVING ESTER GROUPS AND PHOTORESISTS FOR MICROLITHOGRAPHY E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-05-15 WO claimed
CN-115505029-A Cytotoxin molecule, conjugate, preparation method and application thereof 杭州多禧生物科技有限公司 2022-12-23 CN disclosed
CN-114980933-A Compositions and methods for treating viral infections 奇达拉治疗公司 2022-08-30 CN disclosed
CN-113194983-A Compositions and methods for treating viral infections 奇达拉治疗公司 2021-07-30 CN disclosed
CN-110573499-A inhibitors of α v β 6 integrin 莫菲克医疗股份有限公司 2019-12-13 CN disclosed
EP-2949652-B1 Intermediates for the preparation of halichondrin B EISAI R&D MAN CO LTD (JP) 2019-08-07 EP disclosed
US-10301358-B2 Collagen imaging compositions Collagen Medical, LLC (US) 2019-05-28 US disclosed
CN-109180615-A Intermediates for the preparation of analogs of halichondrin B 卫材R&D管理有限公司 2019-01-11 CN disclosed
CN-108997267-A Intermediates for the preparation of analogs of halichondrin B 卫材R&D管理有限公司 2018-12-14 CN disclosed
EP-0816364-A1 Reagents for lysergic acid diethylamide immunoassay F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 EP disclosed
US-5624928-A Method of synthesizing an endonuclease inhibitor and analogs thereof MERCK & CO., INC. (US) 1997-04-29 US disclosed
US-5482699-A Multinuclear complexes for x-ray imaging NYCOMED SALUTAR INC. (US) 1996-01-09 US disclosed
EP-0658157-A1 DIARYL PIPERAZINOACETAMIDE COMPOUNDS AS ANTIMUSCARINIC AGENTS MERRELL PHARMACEUTICALS INC. (US) 1995-06-21 EP disclosed
WO-1994005648-A1 DIARYL PIPERAZINOACETAMIDE COMPOUNDS AS ANTIMUSCARINIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-03-17 WO disclosed
EP-0577675-A1 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1994-01-12 EP disclosed
WO-1992017215-A1 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1992-10-15 WO disclosed
US-4256761-A Antihypertensive amides USV PHARMACEUTICAL CORPORATION (US) 1981-03-17 US disclosed